integrated Filing

Qualified audit opinionEmphasis of matterResults restatedNet loss reportedAuditor changed mid-yearRelated-party transactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹406.95

prior close

₹392.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+3.0% vs market

Pharmaceuticals peers, median of 147sector+0.1%+2.8% vs sector

On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 2.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.8

10m

-4.8

15m

-3.4

30m

-2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-0.1+3.0+0.1+2.8

Next day

+1.2+0.2+1.0-0.0+1.3

+3.9+0.6+3.3+0.8+3.2

+3.2+0.9+2.3+0.3+2.9

+2.7+1.0+1.7+0.0+2.7

+4.4+0.7+3.7-0.7+5.0

+11.8+1.8+10.0-0.1+11.9

15d

+15.8+1.7+14.1-0.9+16.6

+43.8+3.1+40.7-0.8+44.6

+23.3+1.7+21.6+0.4+22.9

+20.0-1.0+21.1-3.0+23.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kerala Ayurveda Ltd reported FY25 standalone revenue from operations of Rs. 7,268.92 lakhs, up about 6.8% from Rs. 6,803.65 lakhs (restated) in FY24. However, the company swung to a sharp net loss of Rs. 1,377.98 lakhs in FY25 versus a Rs. 5.32 lakh profit a year ago, with EPS at Rs. (114.52). Total expenses surged to Rs. 9,134 lakhs, driven by employee costs jumping to Rs. 3,551 lakhs and a Rs. 622 lakh ESOP charge. Cash and cash equivalents collapsed from Rs. 1,649 lakhs to just Rs. 36 lakhs, while total borrowings stand at Rs. 5,411 lakhs against equity of Rs. 2,513 lakhs. Statutory auditor G. Joseph & Associates issued a Qualified Opinion due to an unconfirmed Rs. 3.85 lakh bank balance and an Emphasis of Matter on the restatement of prior period figures under Ind AS 8 covering lease assets, deferred expenditure, loans to subsidiaries, investments, and trade receivables. The board also approved a new Company Secretary, new internal auditor, and a near-doubling of the ESOP pool from 6.66 lakh to 12.03 lakh shares, with an EGM called for June 18, 2025 to approve related-party transactions with Ayurvedagram Heritage Wellness Centre.

Likely market impact

Shareholders should note the significant FY25 loss, prior-period restatement that shaved nearly Rs. 960 lakhs off previously reported equity, and a Qualified audit opinion — though the qualification itself is minor (Rs. 3.85 lakhs). The combination of surging losses, depleted cash, high borrowings, related-party dealings needing shareholder approval, and a potential equity dilution from the expanded ESOP pool is a mixed-to-negative signal for the stock in the near term.